DePuy Synthes and AO Sign Five Year Cooperation Agreement


Johnson & Johnson’s DePuy Synthes Companies will continue to align itself with the AO Foundation following the signing of a five-year cooperation agreement that promises to deliver a continuing stream of products, all integrated into the world famous AO educational programs worldwide.

Background

Founded in 1958, the AO Foundation provides professional education to surgeons, operating room personnel, and scientists in more than 100 countries. The newly signed agreement signals continuance of the work the entities began together in 1960 to deliver world-class professional education and develop new innovations that improve patient outcomes and increase efficiency of care.

Through the agreement, effectively an extension of a lengthy relationship, DePuy Synthes Companies will be the key industry partner for the AO Technical Commission (AOTK) for each of its specialty areas: trauma and corrective surgery of the musculoskeletal system, spine, craniomaxillofacial, veterinary products and related instruments and implants. The AO Specialties continually redefine the state-of-the-art in their respective fields, maintaining activities in research, development, clinical investigation and education.

The two independent organizations will collaborate on innovation and certification of new DePuy Synthes Companies products by AOTK that will then be used in AO educational activities. More than 200,000 health care professionals are expected to participate in AO programs globally over the next five years.

Company comments

“The AO Foundation and DePuy Synthes Companies have maintained a strong relationship for 55 years because of a shared passion for advancing patient care,” said Ciro Roemer, Company Group Chairman, DePuy Synthes Companies International Markets. “Bringing together the unique perspectives of DePuy Synthes Companies and the AO will help us accurately identify and effectively solve the most pressing clinical issues in musculoskeletal surgery and then teach clinicians to appropriately use those solutions.”

Source: DePuy, Synthes Companies 

Share your thoughts

Your email address will not be published. Required fields are marked *